Point72 Asset Management
ALXO icon

Point72 Asset Management’s ALX Oncology ALXO Stock Holding History

Point72 Asset Management’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$82.4K Buy
41,095
+20,878
+103% +$39.8K ﹤0.01% 3630
2025
Q4 		$22.8K Buy
+20,217
New +$30.6K ﹤0.01% 3829
2024
Q3 		– Sell
-304,100
Closed -$1.83M – 1954
2024
Q2 		$1.83M Buy
+304,100
New +$3.74M ﹤0.01% 1119
2024
Q1 		– Sell
-913,700
Closed -$13.6M – 2142
2023
Q4 		$13.6M Buy
+913,700
New +$8.67M 0.03% 579
2023
Q2 		– Sell
-13,556
Closed -$61.3K – 2135
2023
Q1 		$61.3K Sell
13,556
-71,444
-84% -$541K ﹤0.01% 1747
2022
Q4 		$958K Sell
85,000
-297,500
-78% -$3.34M ﹤0.01% 1055
2022
Q3 		$3.66M Buy
+382,500
New +$4.46M 0.01% 809

Other funds holding ALXO

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return

Point72 Asset Management's ALXO Position: Q1 2026 in Review

Point72 Asset Management increased its ALX Oncology (ALXO) stake by 103% in Q1 2026, buying an estimated $39.8K and bringing the position to 41,095 shares worth $82.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3630.

Point72 Asset Management first reported a position in ALXO in Q3 2022 and has held it in 7 quarters since. The position peaked at $13.6M in Q4 2023. 69 funds tracked by Wall St. Rank hold ALXO as of Q1 2026.

  • Point72 Asset Management held 41,095 shares of ALX Oncology worth $82.4K as of Q1 2026.
  • Point72 Asset Management bought 20,878 ALX Oncology shares in Q1 2026, an estimated $39.8K.
  • ALX Oncology made up ﹤0.01% of Point72 Asset Management's portfolio in Q1 2026, its #3630 holding.
  • Point72 Asset Management first reported a position in ALX Oncology in Q3 2022 and has held it in 7 quarters since.
  • Point72 Asset Management's ALX Oncology position peaked at $13.6M in Q4 2023.
  • 69 funds tracked by Wall St. Rank held ALX Oncology as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.